Fernando Martinez to Antihypertensive Agents
This is a "connection" page, showing publications Fernando Martinez has written about Antihypertensive Agents.
Connection Strength
0.249
-
King TE, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Jul 01; 184(1):92-9.
Score: 0.082
-
Redon J, Martinez F, Cheung AK. Special considerations for antihypertensive agents in dialysis patients. Blood Purif. 2010; 29(2):93-8.
Score: 0.075
-
Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019 01; 53(1).
Score: 0.035
-
Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J. 2018 09 01; 39(33):3128-3134.
Score: 0.034
-
Carretta R, Trenkwalder P, Martinez F, Tykarski A, Teitelbaum I, Fagan T, Oddou P, Mallion J. Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapy. J Int Med Res. 2003 Sep-Oct; 31(5):370-7.
Score: 0.012
-
Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J. 2001 Apr; 17(4):647-52.
Score: 0.010